Maze Therapeutics Inc (MAZE)
33.02
+0.34%
Maze Therapeutics Inc (MAZE) is currently trading at $33.02. This represents a gain of 0.34% from the previous session. With a market capitalization of $1.45B, MAZE is a key component of the Health Care sector. Investors looking to trade MAZE should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade MAZE commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Maze Therapeutics Inc (MAZE) shows a bullish trend. Analysts are watching the 33.33 level closely.
Fundamentals
Mkt Cap1.45B
P/E Ratio0.0000
Volume6,283
60-Day Technical Chart
Advanced Charting
Need more indicators for MAZE? Use the world's #1 platform.
Open MAZE on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $33
| Metric |
MAZE +0.34% |
FIG +9.77% |
WOW +12.97% |
IONQ +6.80% |
|---|---|---|---|---|
| Price | $33.02 | $30.03 | $35.63 | $33.76 |
| Mkt Cap | $1.45B | $15.59B | $43.53B | $12.10B |
| - | View → | View → | View → |
Latest Headlines
Behavioral Patterns of MAZE and Institutional Flows
Stock Traders Daily • Feb 21, 2026
Maze Therapeutics has jumped more than 80% in 3 months. Its CEO is bullish on what’s to come
CNBC • Oct 28, 2025
Maze Therapeutics stock price target reiterated at $60 by H.C. Wainwright
Investing.com • Jan 28, 2026
Why Maze Therapeutics, Up 55%, Was Shocked By Its Own Test Results
Investor's Business Daily • Sep 11, 2025
Evaluating Maze Therapeutics (MAZE): Is the Current Valuation Justified After Recent Volatility?
Yahoo Finance • Nov 11, 2025
● Gemini Agentic AI Analyst Insight for MAZE
Market Education
- I am a newbie Trader, how do I start trading Jul 15, 2023
- Making Sense of Money: How Interest Rates, Bonds, and Stocks Affect Your Wallet Feb 21, 2024
- Stock Valuation Dec 16, 2023
External Research